Current treatment options for secondary hyperparathyroidism in patients with stage 3 to 4 chronic kidney disease and vitamin D deficiencyAndrea Galassi, Mario Cozzolino, Paola Ciceri et al.|Expert Opinion on Drug Safety|2021Cited by 10
SARS‐CoV‐2–related ARDS in a maintenance hemodialysis patient: case report on tailored approach by daily hemodialysis, noninvasive ventilation, tocilizumab, anxiolytics, and point‐of‐care ultrasoundAndrea Galassi, Mario Cozzolino, Elena Restelli et al.|Clinical Case Reports|2020Cited by 4
Forced diuresis oriented by point‐of‐care ultrasound in cardiorenal syndrome type 5 due to light chain myeloma—The role of hepatic venogram: A case reportAndrea Galassi, Mario Cozzolino, Lorenza Magagnoli et al.|Clinical Case Reports|2021Cited by 3
Association between Blood Flow Measured within 30 Days from Arteriovenous Access Creation and Thrombosis RiskGiacomo Scherini, Mario Cozzolino, Lorenza Magagnoli et al.|Blood Purification|2025Cited by 0
Efficacy and Safety of Etelcalcetide in Hemodialysis Patients with Moderate to Severe Secondary HyperparathyroidismPaola Monciino, Mario Cozzolino, Lorenza Magagnoli et al.|Kidney and Dialysis|2022Cited by 0